| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2011PLoSO...622374F |
| P356 | DOI | 10.1371/JOURNAL.PONE.0022374 |
| P932 | PMC publication ID | 3149057 |
| P698 | PubMed publication ID | 21829620 |
| P5875 | ResearchGate publication ID | 51559933 |
| P50 | author | Michal Schwartz | Q21264411 |
| Ayal Ronen | Q125288774 | ||
| Akop Seksenyan | Q125289982 | ||
| Tamara Berkutzki | Q125290233 | ||
| Arseny Finkelstein | Q67212289 | ||
| Maya Koronyo-Hamaoui | Q77526984 | ||
| P2093 | author name string | Gilad Kunis | |
| David Azoulay | |||
| P2860 | cites work | SOD1 mutations disrupt redox-sensitive Rac regulation of NADPH oxidase in a familial ALS model | Q24307703 |
| Nasal vaccination with a proteosome-based adjuvant and glatiramer acetate clears beta-amyloid in a mouse model of Alzheimer disease | Q24534813 | ||
| Neuroprotective autoimmunity: naturally occurring CD4+CD25+ regulatory T cells suppress the ability to withstand injury to the central nervous system | Q24539880 | ||
| Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model | Q24631645 | ||
| Posttraumatic therapeutic vaccination with modified myelin self-antigen prevents complete paralysis while avoiding autoimmune disease | Q24671661 | ||
| Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1 | Q24676445 | ||
| Therapeutic vaccine for acute and chronic motor neuron diseases: implications for amyotrophic lateral sclerosis | Q24681228 | ||
| Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis | Q28131805 | ||
| CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides | Q28254991 | ||
| Mini review: immune response to myelin-derived sulfatide and CNS-demyelination | Q28265793 | ||
| Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons | Q28298056 | ||
| Insulin-like growth factors and their binding proteins: biological actions | Q28301853 | ||
| CD1 recognition by mouse NK1+ T lymphocytes | Q28591238 | ||
| Unraveling the mechanisms involved in motor neuron degeneration in ALS | Q29619073 | ||
| Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis | Q29619430 | ||
| Onset and progression in inherited ALS determined by motor neurons and microglia | Q29619515 | ||
| Antigenic specificity of immunoprotective therapeutic vaccination for glaucoma | Q33187884 | ||
| Adaptive immune neuroprotection in G93A-SOD1 amyotrophic lateral sclerosis mice | Q33354106 | ||
| NKG2A inhibits invariant NKT cell activation in hepatic injury | Q33739557 | ||
| Immature myeloid cells induced by a high-fat diet contribute to liver inflammation. | Q33781288 | ||
| Glycolipid antigen induces long-term natural killer T cell anergy in mice | Q33930869 | ||
| Protective autoimmunity is a physiological response to CNS trauma. | Q33947118 | ||
| Limited effects of glatiramer acetate in the high-copy number hSOD1-G93A mouse model of ALS | Q80540415 | ||
| Hepatocyte proliferation during liver regeneration is impaired in mice with liver-specific IGF-1R knockout | Q82581005 | ||
| Natural killer T cells regulate the homing of chemokine CXC receptor 3-positive regulatory T cells to the liver in mice | Q83179770 | ||
| A modified alpha-galactosyl ceramide for staining and stimulating natural killer T cells | Q83220628 | ||
| Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model | Q51659718 | ||
| Selective ablation of bone marrow-derived dendritic cells increases amyloid plaques in a mouse Alzheimer's disease model. | Q53287908 | ||
| An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria | Q54965159 | ||
| Choroid Plexus Megalin Is Involved in Neuroprotection by Serum Insulin-Like Growth Factor I | Q60693600 | ||
| Functional and morphometric study of the liver in motor neuron disease | Q70113581 | ||
| Gangliosides of human spinal cord: aberrant composition of cords from patients with amyotrophic lateral sclerosis | Q70679263 | ||
| Sialosylglobotetraosylceramide: a marker for amyotropic lateral sclerosis | Q71269642 | ||
| Functional natural killer T cells in experimental mouse strains, including NK1.1- strains | Q73277872 | ||
| Cell-specific localization of insulin-like growth factor binding protein mRNAs in rat liver | Q73536584 | ||
| Circulating V(alpha24+) Vbeta11+ NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage | Q74243201 | ||
| Massive Mitochondrial Degeneration in Motor Neurons Triggers the Onset of Amyotrophic Lateral Sclerosis in Mice Expressing a Mutant SOD1 | Q74454204 | ||
| NKT cells inhibit the onset of diabetes by impairing the development of pathogenic T cells specific for pancreatic beta cells | Q78651183 | ||
| Therapeutic immunization with a glatiramer acetate derivative does not alter survival in G93A and G37R SOD1 mouse models of familial ALS | Q79716540 | ||
| Oral tolerance to nickel requires CD4+ invariant NKT cells for the infectious spread of tolerance and the induction of specific regulatory T cells | Q80304558 | ||
| Mutant SOD1(G93A) microglia are more neurotoxic relative to wild-type microglia | Q80445359 | ||
| Dyslipidemia is a protective factor in amyotrophic lateral sclerosis | Q80503053 | ||
| NKT cell stimulation with glycolipid antigen in vivo: costimulation-dependent expansion, Bim-dependent contraction, and hyporesponsiveness to further antigenic challenge | Q34333607 | ||
| Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy | Q34486849 | ||
| Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis | Q35094527 | ||
| T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: possible therapy for optic neuropathies | Q35160575 | ||
| Natural killer T cells: natural or unnatural regulators of autoimmunity? | Q35589842 | ||
| Insulin-like growth factor binding protein (IGFBP) signalling | Q35825099 | ||
| Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor | Q35997495 | ||
| MyD88-deficient bone marrow cells accelerate onset and reduce survival in a mouse model of amyotrophic lateral sclerosis | Q36274514 | ||
| Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice | Q36392687 | ||
| CD4+CD25+ Tregs and NKT cells: regulators regulating regulators | Q36492658 | ||
| Type I NKT cells protect (and type II NKT cells suppress) the host's innate antitumor immune response to a B-cell lymphoma. | Q36713547 | ||
| CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS. | Q36899833 | ||
| T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS. | Q36968498 | ||
| Activation of invariant NKT cells ameliorates experimental ocular autoimmunity by a mechanism involving innate IFN-gamma production and dampening of the adaptive Th1 and Th17 responses | Q37002932 | ||
| Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice | Q37003128 | ||
| Myeloid-derived suppressor cell role in tumor-related inflammation | Q37146806 | ||
| Immunity to self and self-maintenance: what can tumor immunology teach us about ALS and Alzheimer's disease? | Q37153110 | ||
| Application of glatiramer acetate to neurodegenerative diseases beyond multiple sclerosis: the need for disease-specific approaches | Q37263175 | ||
| Murine CD8+ regulatory T lymphocytes: the new era. | Q37279458 | ||
| Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model | Q37285915 | ||
| Thymic involution, a co-morbidity factor in amyotrophic lateral sclerosis | Q37295387 | ||
| Systemic inflammatory cells fight off neurodegenerative disease | Q37763505 | ||
| Protective autoimmunity: interferon-gamma enables microglia to remove glutamate without evoking inflammatory mediators. | Q38330556 | ||
| Invariant NKT cells regulate experimental autoimmune encephalomyelitis and infiltrate the central nervous system in a CD1d-independent manner | Q38476162 | ||
| Cutting edge: V alpha 14-J alpha 281 NKT cells naturally regulate experimental autoimmune encephalomyelitis in nonobese diabetic mice. | Q38495710 | ||
| Massive hepatic apoptosis associated with TGF-beta1 activation after Fas ligand treatment of IGF binding protein-1-deficient mice | Q39740877 | ||
| Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis | Q42049901 | ||
| Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue | Q44172339 | ||
| Role of Vα 14 NKT cells in the development of impaired liver regeneration in vivo | Q44632301 | ||
| Ablation of proliferating microglia does not affect motor neuron degeneration in amyotrophic lateral sclerosis caused by mutant superoxide dismutase. | Q46325370 | ||
| Ganglioside patterns in amyotrophic lateral sclerosis brain regions | Q48472144 | ||
| Neuroprotection by IL-10-producing MOG CD4+ T cells following ischemic stroke | Q48886218 | ||
| Inflammation in amyotrophic lateral sclerosis spinal cord and brain is mediated by activated macrophages, mast cells and T cells | Q48949631 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | amyotrophic lateral sclerosis | Q206901 |
| P304 | page(s) | e22374 | |
| P577 | publication date | 2011-08-02 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Abnormal changes in NKT cells, the IGF-1 axis, and liver pathology in an animal model of ALS | |
| P478 | volume | 6 |
| Q37337058 | A(a)LS: Ammonia-induced amyotrophic lateral sclerosis |
| Q92554706 | Abnormal fatty acid metabolism is a core component of spinal muscular atrophy |
| Q89820662 | Activated Bone Marrow-Derived Macrophages Eradicate Alzheimer's-Related Aβ42 Oligomers and Protect Synapses |
| Q35996589 | Bee Venom Acupuncture Augments Anti-Inflammation in the Peripheral Organs of hSOD1G93A Transgenic Mice |
| Q35548033 | Beneficial effects of canagliflozin in combination with pioglitazone on insulin sensitivity in rodent models of obese type 2 diabetes |
| Q37379980 | Beta-2 microglobulin is important for disease progression in a murine model for amyotrophic lateral sclerosis. |
| Q38543215 | CD4 + T Cells and Neuroprotection: Relevance to Motoneuron Injury and Disease. |
| Q35893142 | Cerebral nitric oxide represses choroid plexus NFκB-dependent gateway activity for leukocyte trafficking |
| Q36299228 | Characterization of the Contribution of Genetic Background and Gender to Disease Progression in the SOD1 G93A Mouse Model of Amyotrophic Lateral Sclerosis: A Meta-Analysis |
| Q47253322 | Correlation of Peripheral Immunity With Rapid Amyotrophic Lateral Sclerosis Progression. |
| Q53793034 | Cu,Zn-SOD deficiency induces the accumulation of hepatic collagen |
| Q27303916 | Early functional deficit and microglial disturbances in a mouse model of amyotrophic lateral sclerosis |
| Q28743158 | Excess Circulating Alternatively Activated Myeloid (M2) Cells Accelerate ALS Progression While Inhibiting Experimental Autoimmune Encephalomyelitis |
| Q38214532 | Glial cells in amyotrophic lateral sclerosis |
| Q38123758 | Immune-mediated mechanisms in the pathoprogression of amyotrophic lateral sclerosis |
| Q38883240 | Immunization with a Myelin-Derived Antigen Activates the Brain's Choroid Plexus for Recruitment of Immunoregulatory Cells to the CNS and Attenuates Disease Progression in a Mouse Model of ALS. |
| Q41488916 | Inflammatory and non-inflammatory monocytes as novel prognostic biomarkers of survival in SOD1G93A mouse model of Amyotrophic Lateral Sclerosis. |
| Q89478133 | Insulin-like growth factor 1 signaling in motor neuron and polyglutamine diseases: From molecular pathogenesis to therapeutic perspectives |
| Q58612356 | Machine Learning Reveals Protein Signatures in CSF and Plasma Fluids of Clinical Value for ALS |
| Q37700144 | Melittin ameliorates the inflammation of organs in an amyotrophic lateral sclerosis animal model |
| Q64900090 | NKT Cells in Neurological Diseases. |
| Q91892005 | Natural killer cells modulate motor neuron-immune cell cross talk in models of Amyotrophic Lateral Sclerosis |
| Q37322677 | Neuroimmunity dynamics and the development of therapeutic strategies for amyotrophic lateral sclerosis |
| Q41824699 | Neuroinflammation as the Proximate Cause of Signature Pathogenic Pattern Progression in Amyotrophic Lateral Sclerosis, Aids, and Multiple Sclerosis |
| Q36026905 | Neuronal and epithelial cell rescue resolves chronic systemic inflammation in the lipid storage disorder Niemann-Pick C. |
| Q41488070 | Role of Neuroinflammation in Amyotrophic Lateral Sclerosis: Cellular Mechanisms and Therapeutic Implications |
| Q36494315 | State of the field: An informatics-based systematic review of the SOD1-G93A amyotrophic lateral sclerosis transgenic mouse model |
| Q90615812 | Temporal evolution of the microbiome, immune system and epigenome with disease progression in ALS mice |
| Q44588281 | The Balance Between Normal and Tumor Tissues in Phototherapy of Tissues Harboring Cancer |
| Q94561279 | The Peripheral Immune System and Amyotrophic Lateral Sclerosis |
| Q38577066 | The interplay between metabolic homeostasis and neurodegeneration: insights into the neurometabolic nature of amyotrophic lateral sclerosis. |
| Q38093477 | The role of glutamate and the immune system in organophosphate-induced CNS damage. |
| Q36332951 | Type I Vs. Type II Cytokine Levels as a Function of SOD1 G93A Mouse Amyotrophic Lateral Sclerosis Disease Progression |
| Q61817013 | iNKT Cell Activation Exacerbates the Development of Huntington's Disease in R6/2 Transgenic Mice |
Search more.